Abiopharma

News list

COMPASS THERAPEUTICS, INC. (CMPX)

SEC News
May 05, 2026, 11:30 UTC

(30% Negative) COMPASS THERAPEUTICS, INC. (CMPX) Reports Q2 2026 Financial Results

Full text

News bot May 5, 2026, 11:31 a.m.

📋 COMPASS THERAPEUTICS, INC. (CMPX) - Financial Results

Filing Date: 2026-05-05

Accepted: 2026-05-05 07:30:18

Event Type: Financial Results

Event Details:

COMPASS THERAPEUTICS, INC. (CMPX) Reports the reporting period Financial Results COMPASS THERAPEUTICS, INC. (CMPX) announced its financial results for the period ending the reporting period. Key Financial Highlights:

Revenue: Not disclosed
Net Income: Not disclosed
EPS: Not disclosed
Cash and equivalents: 55168
- expected in the fourth quarter of 2026
- expected in the second half of 2026

📊 Key Financial Metrics (Year-over-Year Comparison):

Metric	2026	2025	Change ($)	Change (%)
Operating Expenses Loss From Operations	20.30K	17.97K	$2.33K	+12.99%
Operating Expenses Interest Income	1.98K	1.33K	$649.00	+48.69%
Operating Expenses Net Loss	18.32K	16.63K	$1.68K	+10.12%
Operating Expenses Net Loss Per Share	0.10	0.12	$-0.02	-16.67%
Current Assets Prepaid Expenses Other Current Assets	1.00K	1.00K	$0.00	+0.00%
Current Assets Property Equipment Net	169.00	169.00	$0.00	+0.00%
Current Assets Operating Lease Right Of Use Assets	8.75K	8.75K	$0.00	+0.00%
Current Assets Other Assets	568.00	568.00	$0.00	+0.00%
Current Liabilities Accounts Payable	906.00	906.00	$0.00	+0.00%
Loss from Operations	20.30K	20.30K	$0.00	+0.00%
Interest Income	1.98K	1.98K	$0.00	+0.00%
Net Loss	18.32K	18.32K	$0.00	+0.00%
Prepaid Expenses and Other Current Assets	1.00K	1.00K	$0.00	+0.00%
Property and Equipment, Net	169.00	169.00	$0.00	+0.00%
Other Assets	568.00	568.00	$0.00	+0.00%
Accounts Payable	906.00	906.00	$0.00	+0.00%

💼 Business Developments:

Partnership: Not available
Acquisition: Not available
Licensing: Not available
Regulatory Approval
Executive Changes: Not available

Structured Data:

Company Name: COMPASS THERAPEUTICS, INC.
Ticker Symbol: CMPX